European Paediatric Cancer Community Proposal for Improvement of the EU Revised Pharmaceutical Legislation

European Paediatric Cancer Community Proposal for Improvement of the EU Revised Pharmaceutical Legislation On April 26th 2023, the European Commission released a proposal for revision of the Pharmaceutical legislation, which includes provisions on medicines for paediatric and rare diseases. Over the summer, CCI-E's and SIOPE's policy teams carried out an

Statement on the EU Pharmaceutical Proposal

Statement on the EU Pharmaceutical Proposal . The European Society for Paediatric Oncology (SIOP Europe), the single united European organisation representing healthcare professionals and researchers in paediatric oncology, and Childhood Cancer International – Europe (CCI Europe), the largest European patient organisation representing childhood cancer patients, parents and survivors, have been involved

The European Childhood Cancer Community Urgently Calls for the Release of the Proposal of the Revised EU Pharmaceutical legislation

. The European Childhood Cancer Community Urgently Calls for the Release of the Proposal of the Revised EU Pharmaceutical legislation The European Society for Paediatric Oncology (SIOP Europe), the single united European organisation representing healthcare professionals and researchers in paediatric oncology, and Childhood Cancer International – Europe (CCI Europe), the largest European

Psychosocial Care in Paediatric Oncology in Europe: Outcomes of survey among childhood cancer organisations

. Psychosocial Care in Paediatric Oncology in Europe: Outcomes of survey among childhood cancer organisations Youth with cancer and their family members should routinely receive systematic assessments of their psychosocial health care needs and have access to it throughout the cancer trajectory as needed. As a Europe-wide umbrella organisation, CCI Europe observed

Go to Top